Correlation Between Neurocrine Biosciences and Catalent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Catalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Catalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Catalent, you can compare the effects of market volatilities on Neurocrine Biosciences and Catalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Catalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Catalent.

Diversification Opportunities for Neurocrine Biosciences and Catalent

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neurocrine and Catalent is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Catalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalent and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Catalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalent has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Catalent go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Catalent

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 3.3 times more return on investment than Catalent. However, Neurocrine Biosciences is 3.3 times more volatile than Catalent. It trades about 0.17 of its potential returns per unit of risk. Catalent is currently generating about 0.03 per unit of risk. If you would invest  11,508  in Neurocrine Biosciences on August 24, 2024 and sell it today you would earn a total of  992.00  from holding Neurocrine Biosciences or generate 8.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  Catalent

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Catalent 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Catalent are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable essential indicators, Catalent is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Neurocrine Biosciences and Catalent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and Catalent

The main advantage of trading using opposite Neurocrine Biosciences and Catalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Catalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will offset losses from the drop in Catalent's long position.
The idea behind Neurocrine Biosciences and Catalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk